Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HOLOGIC INCHOLX · Entity 12463 | Director | March 07, 2024 | March 11, 2024 |
| INSULET CORPPODD · Entity 3516 | Director | June 04, 2021 | June 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HOLOGIC INC
Report date March 07, 2024 · Filed March 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,927 |
Ending reported balance
After 2024-03-08 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-03-07 · Grant · Acquired 1,572 · Balance 132,927 F1: Represents restricted stock units which vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock. F2: Restricted stock units are settled in shares of common stock on a one-for-one basis. Row 2 · 2024-03-08 · Exercise / conversion · Acquired 9,039 · Balance 141,966 Row 3 · 2024-03-08 · Sale · Disposed 9,039 · Balance 132,927 F3: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $76.40 to $76.43 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $76.32 · Expires 2034-03-07 | Direct | 4,536 |
Reported balance
After 2024-03-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-03-07 · Grant · Acquired 4,536 · Balance 4,536 F4: Options become exercisable on the date of the 2025 Annual Meeting of Stockholders. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.74 · Expires 2025-01-01 | Direct | 0 |
Reported balance
After 2024-03-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-03-08 · Exercise / conversion · Disposed 9,039 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units which vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock.
F2: Restricted stock units are settled in shares of common stock on a one-for-one basis.
F3: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $76.40 to $76.43 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F4: Options become exercisable on the date of the 2025 Annual Meeting of Stockholders.
INSULET CORP
Report date June 04, 2021 · Filed June 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,306 |
Reported balance
After 2021-06-04 transaction · row 1
1 source rowRow 1 · 2021-06-04 · Sale · Disposed 10,000 · Balance 20,306 F1: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $266.885 to $273.090. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $266.885 to $273.090. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
UNIVERSAL AMERICAN CORP.
Report date April 28, 2017 · Filed May 02, 2017
Section 16 reporting ended · disclosed 2017-05-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-04-28 transaction · row 1
1 source rowRow 1 · 2017-04-28 · Disposition to issuer · Disposed 76,244 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.46 | Direct | 0 |
Reported balance
After 2017-04-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-04-28 · Disposition to issuer · Disposed 24,511 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.81 | Direct | 0 |
Reported balance
After 2017-04-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-04-28 · Disposition to issuer · Disposed 29,565 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.21 | Direct | 0 |
Reported balance
After 2017-04-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-04-28 · Disposition to issuer · Disposed 25,859 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
F2: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time.
ZimVie Inc.
Report date October 20, 2025 · Filed October 20, 2025
Section 16 reporting ended · disclosed 2025-10-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-10-20 transaction · row 1
1 source rowRow 1 · 2025-10-20 · Disposition to issuer · Disposed 40,127 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation ("Parent"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent ("MergerCo"), pursuant to which, on October 20, 2025 (the "Effective Time"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the "Merger Consideration"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled. |
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-10-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-10-20 · Disposition to issuer · Disposed 6,755.864 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation ("Parent"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent ("MergerCo"), pursuant to which, on October 20, 2025 (the "Effective Time"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the "Merger Consideration"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled. F2: At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a "Deferred Share Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration. F4: As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Ms. Crawford. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-10-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-10-20 · Disposition to issuer · Disposed 57,728 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation ("Parent"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent ("MergerCo"), pursuant to which, on October 20, 2025 (the "Effective Time"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the "Merger Consideration"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled. F3: At the Effective Time, each restricted stock unit with respect to Common Stock (each, a "Restricted Stock Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock. F4: As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Ms. Crawford. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation ("Parent"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent ("MergerCo"), pursuant to which, on October 20, 2025 (the "Effective Time"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the "Merger Consideration"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled.
F2: At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a "Deferred Share Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration.
F3: At the Effective Time, each restricted stock unit with respect to Common Stock (each, a "Restricted Stock Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock.
F4: As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Ms. Crawford.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2025 Filed Oct 20, 2025 17:35 UTC | ZimVie Inc. ZIMV · Entity 74112 | Disposition to issuerRestricted Stock Units · Derivative | 57,728 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-243820 · ownership.xml · derivative · entry 3 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,728 shares Expires not disclosed F1 · derivative.exercise_price: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation ("Parent"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent ("MergerCo"), pursuant to which, on October 20, 2025 (the "Effective Time"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the "Merger Consideration"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled. F3 · derivative.exercise_price: At the Effective Time, each restricted stock unit with respect to Common Stock (each, a "Restricted Stock Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock. F3 · price: At the Effective Time, each restricted stock unit with respect to Common Stock (each, a "Restricted Stock Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: At the Effective Time, each restricted stock unit with respect to Common Stock (each, a "Restricted Stock Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock. F4 · derivative.exercise_date: As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Ms. Crawford. F3 · derivative.expiration_date: At the Effective Time, each restricted stock unit with respect to Common Stock (each, a "Restricted Stock Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Each Restricted Stock Unit represented a contingent right to receive one share of Common Stock. F4 · derivative.expiration_date: As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Ms. Crawford. Read SEC document |
| October 20, 2025 Filed Oct 20, 2025 17:35 UTC | ZimVie Inc. ZIMV · Entity 74112 | Disposition to issuerDeferred Share Units · Derivative | 6,755.864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-243820 · ownership.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,755.864 shares Expires not disclosed F1 · derivative.exercise_price: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation ("Parent"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent ("MergerCo"), pursuant to which, on October 20, 2025 (the "Effective Time"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the "Merger Consideration"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled. F2 · derivative.exercise_price: At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a "Deferred Share Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration. F2 · price: At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a "Deferred Share Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration. F2 · derivative.exercise_date: At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a "Deferred Share Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration. F4 · derivative.exercise_date: As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Ms. Crawford. F2 · derivative.expiration_date: At the Effective Time, each deferred share unit (whether settled in cash or in shares of Common Stock, including any such deferred stock unit resulting from the reinvestment of dividend equivalents) (each, a "Deferred Share Unit") outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested) and was canceled and converted into the right to receive cash, without interest and subject to applicable tax withholding and deductions, in an amount equal to the product, rounded to the nearest cent, of (i) the number of shares of Common Stock subject to such Deferred Share Unit immediately prior to the Effective Time and (ii) the Merger Consideration. F4 · derivative.expiration_date: As required by the terms of the Merger Agreement, the Issuer accelerated the vesting, as of immediately prior to the Effective Time, contingent upon the closing of the transactions contemplated by the Merger Agreement, of all of the outstanding and unvested equity awards held by Ms. Crawford. Read SEC document |
| October 20, 2025 Filed Oct 20, 2025 17:35 UTC | ZimVie Inc. ZIMV · Entity 74112 | Disposition to issuerCommon Stock | 40,127 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-243820 · ownership.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated July 20, 2025, by and among the Issuer, Zamboni Parent Inc., a Delaware corporation ("Parent"), and Zamboni MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent ("MergerCo"), pursuant to which, on October 20, 2025 (the "Effective Time"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. At the Effective Time, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), reported on this Form 4 was converted into the right to receive $19.00 in cash (the "Merger Consideration"), without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled. Read SEC document |
| May 07, 2025 Filed May 9, 2025 16:37 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantRestricted Stock Units · Derivative | 21,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-009015 · form4.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,728 Underlying: Common Stock · 21,119 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F4 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 07, 2025 Filed May 9, 2025 16:37 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 500 | $0.00 Strike: $8.76 | $0.00 |
DisclosureSEC source: 0001062993-25-009015 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,755.864 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 15, 2024 Filed May 17, 2024 16:17 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantRestricted Stock Units · Derivative | 11,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010623 · form4.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,609 Underlying: Common Stock · 11,012 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F4 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 15, 2024 Filed May 17, 2024 16:17 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 500 | $0.00 Strike: $16.80 | $0.00 |
DisclosureSEC source: 0001062993-24-010623 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,255.864 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 22:41 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 9,039 | $0.00 Strike: $26.74 | $0.00 |
DisclosureSEC source: 0001127602-24-009474 · form4.xml · derivative · entry 5 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,039 shares Expires 2025-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 22:41 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 9,039 | $76.40 | $690,606.72 |
DisclosureSEC source: 0001127602-24-009474 · form4.xml · nonDerivative · entry 3 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,927 F3 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $76.40 to $76.43 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 22:41 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 9,039 | $26.74 | $241,702.86 |
DisclosureSEC source: 0001127602-24-009474 · form4.xml · nonDerivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,966 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 22:41 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 4,536 | $0.00 Strike: $76.32 | $0.00 |
DisclosureSEC source: 0001127602-24-009474 · form4.xml · derivative · entry 4 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,536 Underlying: Common Stock · 4,536 shares Expires 2034-03-07 F4 · derivative.exercise_date: Options become exercisable on the date of the 2025 Annual Meeting of Stockholders. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 22:41 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-009474 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,927 F1 · shares: Represents restricted stock units which vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 17:22 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 762.86 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001062993-23-014503 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,755.864 Underlying: Common Stock · 762.86 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 12, 2023 Filed May 16, 2023 16:42 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantRestricted Stock Units · Derivative | 17,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-011238 · form4.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,597 Underlying: Common Stock · 17,704 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F4 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 12, 2023 Filed May 16, 2023 16:42 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 500 | $0.00 Strike: $10.45 | $0.00 |
DisclosureSEC source: 0001062993-23-011238 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,993.004 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 16:03 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 1,241.135 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0001062993-23-008467 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,493.004 Underlying: Common Stock · 1,241.135 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 16:04 UTC | ZimVie Inc. ZIMV · Entity 74112 | PurchaseCommon Stock | 40,000 | $5.60 | $224,120.00 |
DisclosureSEC source: 0001062993-23-006934 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,127 F1 · price: Reflects the weighted average price of 40,000 shares of common stock of ZimVie Inc. purchased in multiple transactions on March 13, 2023 with purchase prices ranging from $5.51 to $5.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 20:10 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 4,210 | $0.00 Strike: $78.49 | $0.00 |
DisclosureSEC source: 0001127602-23-009864 · form4.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,210 Underlying: Common Stock · 4,210 shares Expires 2033-03-09 F3 · derivative.exercise_date: Options become exercisable on the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| March 09, 2023 Filed Mar 13, 2023 20:10 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,465 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-009864 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,355 F1 · shares: Represents restricted stock units which vest on the date of the 2024 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 16:02 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 957.33 | $0.00 Strike: $9.14 | $0.00 |
DisclosureSEC source: 0001062993-23-000233 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,251.869 Underlying: Common Stock · 957.33 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 16:07 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 870.647 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0001062993-22-020307 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,294.539 Underlying: Common Stock · 870.647 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 16:03 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 541.796 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001062993-22-015844 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,423.892 Underlying: Common Stock · 541.796 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:17 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantRestricted Stock Units · Derivative | 7,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-009502 · form4.xml · derivative · entry 3 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,893 Underlying: Common Stock · 7,893 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F4 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 17:17 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 500 | $0.00 Strike: $23.44 | $0.00 |
DisclosureSEC source: 0001062993-22-009502 · form4.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 882.096 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 17:17 UTC | ZimVie Inc. ZIMV · Entity 74112 | GrantDeferred Share Units · Derivative | 382.096 | $0.00 Strike: $22.90 | $0.00 |
DisclosureSEC source: 0001062993-22-009502 · form4.xml · derivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382.096 Underlying: Common Stock · 382.096 shares Expires not disclosed F1 · security: The deferred share units were accrued under the ZimVie Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:19 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,293 | $0.00 Strike: $70.28 | $0.00 |
DisclosureSEC source: 0001127602-22-009120 · form4.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,293 Underlying: Common Stock · 5,293 shares Expires 2032-03-10 F3 · derivative.exercise_date: Options become exercisable on the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:19 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,565 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-009120 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,890 F1 · kind: Represents restricted stock units which vest on the date of the 2023 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 20:29 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 10,000 | $269.08 | $2,690,750.00 |
DisclosureSEC source: 0001127602-21-019361 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,306 F1 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $266.885 to $273.090. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:00 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 808 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018302 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,306 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). RSUs vest in full on April 30, 2022 and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:09 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 5,055 | $0.00 Strike: $71.03 | $0.00 |
DisclosureSEC source: 0001127602-21-010620 · form4.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,055 Underlying: Common Stock · 5,055 shares Expires 2031-03-11 F3 · derivative.exercise_date: Option becomes exercisable on the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:09 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 1,478 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010620 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,325 F1 · kind: Represents restricted stock units which vest on the date of 2022 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:55 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018246 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,498 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). RSUs vest in full on April 30, 2021 and are settled in shares of common stock on a one-for-one basis. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:09 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 31,950 | $51.99 | $1,661,080.50 |
DisclosureSEC source: 0001127602-20-017997 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,847 F1 · price: This price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $51.71 to $52.28 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:07 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 11,146 | $0.00 Strike: $22.35 | $0.00 |
DisclosureSEC source: 0001127602-20-010246 · form4.xml · derivative · entry 4 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,146 shares Expires 2021-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:07 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 7,846 | $44.29 | $347,522.88 |
DisclosureSEC source: 0001127602-20-010246 · form4.xml · nonDerivative · entry 3 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,797 F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan. F3 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $44.10 to $44.49 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:07 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 3,300 | $43.57 | $143,794.20 |
DisclosureSEC source: 0001127602-20-010246 · form4.xml · nonDerivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,643 F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan. F2 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $43.235 to $44.082 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 20:07 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 11,146 | $22.35 | $249,113.10 |
DisclosureSEC source: 0001127602-20-010246 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:59 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,322 | $0.00 Strike: $47.36 | $0.00 |
DisclosureSEC source: 0001127602-20-009969 · form4.xml · derivative · entry 2 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,322 Underlying: Common Stock · 7,322 shares Expires 2030-03-05 F3 · derivative.exercise_date: Options become exercisable on the date of the 2021 Annual Meeting of Stockholders. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:59 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 2,217 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-009969 · form4.xml · nonDerivative · entry 1 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,797 F1 · shares: Represents restricted stock units which vest on the date of the 2021 Annual Meeting of Stockholders and are settled in shares of common stock. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $35.11 | $0.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · derivative · entry 16 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2024-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2015, 25% of the total award vesting on April 30, 2016 and 25% of the total award vesting on April 30, 2017, subject to continued service as a director or consultant. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · derivative · entry 15 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2023-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is subject to the following vesting schedule: 50% of the total award shall vest on April 30, 2014, 25% of the total award shall vest on April 30, 2015 and 25% of the total award shall vest on April 30, 2016, subject to continued service as a director or consultant. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $17.75 | $0.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · derivative · entry 14 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2013, 25% of the total award vesting on April 30, 2014 and 25% of the total award vesting on April 30, 2015, subject to continued service as a director or consultant. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $20.90 | $0.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · derivative · entry 13 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2021-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2012, 25% of the total award vesting on April 30, 2013 and 25% of the total award vesting on April 30, 2014, subject to continued service as a director or consultant. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,525 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · derivative · entry 12 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,525 shares Expires 2025-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2016, 25% of the total award vesting on April 30, 2017 and 25% of the total award vesting on April 30, 2018, subject to continued service as a director or consultant. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,587 | $0.00 Strike: $40.60 | $0.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · derivative · entry 11 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,587 shares Expires 2027-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,235 | $0.00 Strike: $28.87 | $0.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · derivative · entry 10 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,235 shares Expires 2026-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | SaleCommon Stock | 28,347 | $108.60 | $3,078,484.20 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · nonDerivative · entry 9 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,469 F2 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. F3 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $106.965 to $110.395. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 4,000 | $35.11 | $140,440.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · nonDerivative · entry 8 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 4,000 | $30.04 | $120,160.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · nonDerivative · entry 7 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:35 UTC | INSULET CORP PODD · Entity 3516 | Exercise / conversionCommon Stock | 4,000 | $17.75 | $71,000.00 |
DisclosureSEC source: 0001127602-19-020530 · form4.xml · nonDerivative · entry 6 CRAWFORD SALLY · CIK 0001199735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.